Page last updated: 2024-08-23

amikacin and Tuberculosis, Drug-Resistant

amikacin has been researched along with Tuberculosis, Drug-Resistant in 87 studies

Research

Studies (87)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (6.90)	18.2507
2000's	11 (12.64)	29.6817
2010's	49 (56.32)	24.3611
2020's	21 (24.14)	2.80

Authors

Authors	Studies
Moreno-Viguri, E; Pérez-Silanes, S; Santivañez-Veliz, M; Torres, E	1
Camoin, L; Canaan, S; Cavalier, JF; Durand, T; Spilling, CD	1
Barilar, I; Cirillo, DM; Farhat, MR; Freschi, L; Köser, CU; Miotto, P; Niemann, S; Spitaleri, A; Tahseen, S; Vargas, R	1
Bhalla, M; Ciobanu, N; Conradie, F; Crudu, V; David, A; Denkinger, CM; Georghiou, SB; Kazi, M; Myneedu, VP; Penn-Nicholson, A; Rodrigues, C; Ruhwald, M; Schumacher, SG; Scott, L	1
Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F	1
Chaplin, M; Davies, GR; De Vos, M; Pillay, S; Schumacher, SG; Steingart, KR; Theron, G; Warren, R	1
Bor, J; de Vos, M; Dolby, T; Horsburgh, CR; Jacobson, KR; Jenkins, HE; Leavitt, SV; Streicher, EM; Sy, KTL; Warren, RM	1
Hsiao, HC; Jou, R; Wu, SH; Xiao, YX	1
Brankin, A; Colman, RE; Georghiou, SB; Seifert, M; Suresh, A; Uplekar, S; Walker, TM	1
Doustdar, F; Eslami, G; Ghalavand, Z; Habibnia, S; Karami-Zarandi, M; Kazemian, H; Zaker, S	1
Catanzaro, A; Catanzaro, DG; Chiles, P; Ciobanu, N; Codreanu, A; Colman, RE; Cooney, CG; Crudu, V; Hillery, N; Holmberg, RC; Kukhtin, AV; Linger, Y; Norville, R; Rodwell, TC; Seifert, M; Syed, RR	1
Anderson, K; Bian, A; Cox, H; Dheda, K; Pietersen, E; Shepherd, BE; Sterling, TR; van der Heijden, YF; Warren, RM	1
Berge, I; Bogdanova, I; Freimane, L; Norvaiša, I; Ozere, I; Ranka, R; Sadovska, D; Vaivode, A; Vīksna, A	1
Adeel, A; Ahmad, A; Ahmad, I; Aslam, H; Mushtaq, F; Raza, SM; Saleem, S	1
Arnold, A; Cooke, GS; Dedicoat, M; Green, N; Harrison, TS; Kon, OM; Lipman, M; Loyse, A; Manalan, K	1
De Maio, F; De Spirito, M; Delogu, G; Fimia, GM; Goletti, D; Maulucci, G; Palucci, I; Petrone, L; Piacentini, M; Romagnoli, A; Sali, M; Sanguinetti, M	1
Budhathoki, C; Dooley, KE; Dowdy, DW; Farley, JE; Francis, HW; Han, HR; Hong, H	1
Erber, J; Rothe, K; Schmid, RM; Schneider, J; Spinner, CD; Tschaikowsky, T; Weidlich, S	1
Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M	1
Chen, J; Chen, X; He, G; Lin, S; Sun, F; Wang, S; Zhang, W	1
Fox, GJ; Ho, J; Redwood, L; Velen, K; Wrohan, I	1
Brar, MS; Brode, SK; Sabur, NF; Wu, L	1
Ahmad, N; Atif, M; Ghafoor, A; Iqbal, Q; Khan, S; Latif, A; Saleem, F; Wahid, A	1
Ahmad, K; Ahmad, Z; Ali, A; Rahat, S; Somayya, R	1
Brouqui, P; Drancourt, M; Fournier, PE; Quenard, F	1
Arnold, A; Chis Ster, I; Cooke, GS; Dedicoat, M; Harrison, TS; Kon, OM; Lipman, M; Loyse, A	1
Akbar, HS; Atta, QM; Gul, F; Hassan, M; Jan, F; Muhammad, N; Wali, S	1
Akkerman, OW; Bathoorn, E; de Lange, WCM; Lokate, M; Louka, C; Pournaras, S; Ravensbergen, SJ; Stienstra, Y; van der Werf, TS	1
Ahmed, P; Gardezi, AH; Ikram, AI; Lalani, FK; Satti, ML; Zaman, G	1
Bourkadi, JE; Chaoui, I; Chetioui, F; El Mzibri, M; Elmessaoudi, MD; Karimi, H; Laglaoui, A; Oudghiri, A; Zakham, F	1
Draper, HR; Garcia-Prats, AJ; Hesseling, AC; McIlleron, HM; Norman, J; Rose, PC; Schaaf, HS; Seddon, JA	1
Ihm, C; Kim, K; Park, J; Park, K; Shin, S; Shin, SY	1
Frota, SMMC; Kritski, AL; Ruffino-Netto, A; Vasconcelos, KA	1
Chaiprasert, A; Phunpruch, S; Prammananan, T; Sowajassatakul, A	1
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M	1
Akkerman, OW; Alffenaar, JC; Bolhuis, MS; Ghimire, S; Simbar, N; Sturkenboom, MGG	1
Bisht, D; Faheem, M; Joshi, B; Khan, AU; Lata, M; Sharma, D; Shukla, S; Venkatesan, K	1
Admasu, A; Berha, AB; Negash, Z; Sheth, AN; Shibeshi, W; Yimer, G	1
Alagna, R; Besozzi, G; Castellotti, P; Cirillo, D; Codecasa, L; De Lorenzo, S; Ferrarese, M; Mazzola, E; Riccardi, N; Saderi, L; Sotgiu, G; Udwadia, Z; Viggiani, P	1
Abdi, H; Arube, P; Dlamini, MG; Joloba, ML; Kamulegeya, R; Kasule, GW; Katabazi, FA; Kateete, DP; Khumalo, D; Kigozi, E; Lukoye, D; Musisi, K; Sebit, SI	1
Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S	1
Capocci, S; Cropley, I; Garcia Medina, R; Hopkins, S; Katiri, S; Lipman, M; Melchionda, V; Solamalai, A; Wyatt, H	1
Gratz, J; Heysell, SK; Houpt, ER; Kibiki, GS; Kumburu, H; Mpagama, SG; Ndusilo, N; Peloquin, CA; Stroup, S	1
Ajbani, K; Catanzaro, A; Caviedes, L; Coronel, J; Crudu, V; Desmond, E; Eisenach, K; Ganiats, TG; Garfein, RS; Groessl, EJ; Jackson, RL; Klages, S; Moore, D; Rodrigues, C; Rodwell, TC; Romancenco, E; Trollip, AP; Victor, T; Vineet, VP	1
Kam, KM; Liu, M; Pang, Y; Wang, Y; Zhang, Z; Zhao, Y	1
Kesenogile, B; Modongo, C; Ncube, R; Sirugo, G; Sobota, RS; Williams, SM; Zetola, NM	1
Alland, D; Barry, CE; Chakravorty, S; Cho, EJ; Cho, SN; Kim, CT; Lee, J; Lee, JS; Roh, SS; Smith, LE; Via, LE	1
Campbell, PJ; Posey, JE; Reeves, AZ; Willby, MJ	1
Broda, A; Casali, N; Drobniewski, F; Gonzalo, X; Pardieu, C	1
Augustynowicz-Kopeć, E; Bakuła, Z; Bielecki, J; Jagielski, T; Kamiński, M; Napiórkowska, A; Zwolska, Z	1
Ader, F; Bouaziz, A; Catho, G; Dumitriescu, O; Pedone, C; Perpoint, T; Reix, P; Ronnaux-Baron, AS; Sénéchal, A; Valour, F	1
Akkerman, OW; Alffenaar, JW; de Lange, WC; Dijkstra, JA; Kosterink, JG; Proost, JH; van Altena, R; van der Werf, TS	1
Gumbo, T; Modongo, C; Pasipanodya, JG; Sirugo, G; Williams, SM; Zetola, NM	1
Huang, H; Ke, Z; Liu, S; Mao, X; Shi, X; Tang, B; Wang, J	1
Leufkens, HG; Mantel-Teeuwisse, AK; Mavhunga, F; Rennie, T; Ruswa, N; Sagwa, EL	1
Sibbald, B	1
Ajbani, K; Catanzaro, A; Georghiou, SB; Kambli, P; Nikam, C; Rodrigues, C; Rodwell, TC; Sadani, M; Shetty, A; Udwadia, Z	1
Aubry, A; Brossier, F; Guindo, D; Pham, A; Reibel, F; Sougakoff, W; Veziris, N	1
Cai, X; Deng, Y; Dong, H; Huan, S; Jing, H; Li, J; Li, Q; Li, X; Ou, X; Pang, Y; Su, B; Tan, Y; Xia, H; Zhang, J; Zhang, Z; Zhao, Y	1
Forsman, LD; Hoffner, S; Hu, Y; Mansjö, M; Werngren, J; Xu, B; Zheng, R; Zheng, X	1
Deshpande, D; Gumbo, T; Modongo, C; Pasipanodya, JG; Siyambalapitiyage Dona, CW; Srivastava, S	1
Gumbo, T; Magazi, BT; Modongo, C; Pasipanodya, JG; Sirugo, G; Srivastava, S; Williams, SM; Zetola, NM	1
Garcia-Prats, AJ; Hesseling, AC; Schaaf, HS	1
Blackmore, T; McNaughton, A; McNaughton, H	1
Aubry, A; Bernard, C; Brossier, F; Jarlier, V; Pham, A; Sougakoff, W; Veziris, N	1
Baghaei, P; Chitsaz, E; Farnia, P; Jalali, S; Kazempour, M; Mansouri, D; Masjedi, MR; Mirsaeidi, M; Tabarsi, P; Velayati, AA	1
Braker, K; Cox, HS; Feuerriegel, S; Karimovich, HA; Niemann, S; Rüsch-Gerdes, S; Zarkua, N	1
Li, C; Sugawara, I; Zhang, J	1
Bzekalava, N; de Rijk, P; Fissette, K; Jugheli, L; Portaels, F; Rigouts, L	1
Metchock, B; Posey, JE; Shinnick, TM; Sikes, RD; Zaunbrecher, MA	1
Dauby, N; Payen, MC	1
Böttger, EC; Chabula-Nxiweni, M; Coetzee, G; Gey van Pittius, NC; Hayes, C; Hoosain, EY; Sirgel, FA; Streicher, EM; Tait, M; Trollip, A; van Helden, PD; Victor, TC; Warren, RM	1
Anthony, RM; Bergval, I; Bosman, M; Böttger, EC; Coetzee, G; Dheda, K; Gey van Pittius, NC; Streicher, EM; van Helden, PD; Victor, TC; Warren, RM	1
Aarnoutse, RE; Bakker-Woudenberg, IA; Boeree, MJ; de Knegt, GJ; de Steenwinkel, JE; Kremer, K; ten Kate, MT; van Soolingen, D; Verbrugh, HA	1
Catanzaro, A; Catanzaro, DG; Garfein, RS; Georghiou, SB; Magana, M; Rodwell, TC	1
Kam, KM; Yip, CW	1
Andrianasolo, D; Ramarokoto, H; Ramaroson, F; Rasolofo Razanamparany, V; Rasolonavalona, T; Ratsimba, L; Razafitsiarovana, I; Vincent, V	1
Farnia, P; Khoshnood, K; Mansoori, SD; Masjedi, H; Masjedi, MR; Mirsaeidi, SM; Mohammadi, F; Pooramiri, MV; Rowhani-Rahbar, A; Tabarsi, P; Velayati, AA; Zahirifard, S	1
Ovsiankina, ES; Panova, LV	1
Carlos, L; da Silva, C; Müller, L	1
Coker, RJ; Fisher, M; Tomlinson, DR	1
Cropley, IM; Davidson, RN; Lovering, AM; Wade, P; Whitehead, TC	1
Chen, M; Qian, H; Zhang, Y	1
Bartsch, P; Corhay, JL; Gach, O; Lousberg, L	1
Chan, CY; Chau, CH; Cheng, AF; Cheung, SW; Leung, CK; Wong, CF; Yew, WW	1
Berning, SE; Cherry, TA; Iseman, MD	1
de Jager, P; van Altena, R	1

Reviews

9 review(s) available for amikacin and Tuberculosis, Drug-Resistant

Article	Year
Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery. European journal of medicinal chemistry, 2021, Jan-01, Volume: 209 Topics: Antitubercular Agents; Carboxylic Ester Hydrolases; Drug Design; Enzyme Inhibitors; Humans; Lactones; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Mycolic Acids; Organophosphorus Compounds; Orlistat; Tuberculosis; Tuberculosis, Multidrug-Resistant	2021
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin. The Cochrane database of systematic reviews, 2022, 05-18, Volume: 5 Topics: Adult; Amikacin; Antibiotics, Antitubercular; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Sensitivity and Specificity; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2022
Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021, 01-01, Volume: 25, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Humans; Ototoxicity; Tuberculosis, Multidrug-Resistant	2021
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet (London, England), 2018, 09-08, Volume: 392, Issue:10150 Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 11-28, Volume: 67, Issue:suppl_3 Topics: Amikacin; Anti-Bacterial Agents; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2018
[Children exposed to multidrug-resistant tuberculosis: How should we manage? Analysis of 46 child contacts and review of the literature]. Revue de pneumologie clinique, 2015, Volume: 71, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Female; France; Humans; Infant; Latent Tuberculosis; Levofloxacin; Lost to Follow-Up; Male; Tuberculosis, Multidrug-Resistant	2015
Diagnosis of Drug Resistance to Fluoroquinolones, Amikacin, Capreomycin, Kanamycin and Ethambutol with Genotype MTBDRsl Assay: a Meta-Analysis. Annals of clinical and laboratory science, 2015,Fall, Volume: 45, Issue:5 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Genotyping Techniques; Humans; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2015
The safety and tolerability of the second-line injectable antituberculosis drugs in children. Expert opinion on drug safety, 2016, Volume: 15, Issue:11 Topics: Adult; Amikacin; Animals; Antitubercular Agents; Capreomycin; Child; Drug Monitoring; Humans; Injections; Kanamycin; Risk Factors; Tuberculosis, Multidrug-Resistant	2016
Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review. PloS one, 2012, Volume: 7, Issue:3 Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Methyltransferases; Mutation; Mycobacterium tuberculosis; Promoter Regions, Genetic; Tuberculosis, Multidrug-Resistant	2012

Trials

6 trial(s) available for amikacin and Tuberculosis, Drug-Resistant

Article	Year
Effect of Coadministration of Lidocaine on the Pain and Pharmacokinetics of Intramuscular Amikacin in Children With Multidrug-Resistant Tuberculosis: A Randomized Crossover Trial. The Pediatric infectious disease journal, 2018, Volume: 37, Issue:12 Topics: Adolescent; Amikacin; Anesthetics, Local; Antitubercular Agents; Area Under Curve; Child; Cross-Over Studies; Double-Blind Method; Female; Humans; Injections, Intramuscular; Lidocaine; Male; Pain Measurement; Pain, Procedural; South Africa; Tuberculosis, Multidrug-Resistant	2018
Is standardized treatment appropriate for non-XDR multiple drug resistant tuberculosis cases? A clinical descriptive study. Scandinavian journal of infectious diseases, 2009, Volume: 41, Issue:1 Topics: Adult; Afghanistan; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2009
Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2005, Volume: 9, Issue:6 Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Cycloserine; Drug Therapy, Combination; Female; Humans; Iran; Isoniazid; Male; Middle Aged; Ofloxacin; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2005
Multidrug-resistant tuberculosis. The New England journal of medicine, 1996, Jan-25, Volume: 334, Issue:4 Topics: Amikacin; Antitubercular Agents; Brazil; Drug Therapy, Combination; HIV Seronegativity; Humans; Quinolones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	1996
[Bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 1997, Volume: 20, Issue:6 Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoscopy; Catheterization, Peripheral; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ofloxacin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1997
Serum pharmacokinetics of antimycobacterial drugs in patients with multidrug-resistant tuberculosis during therapy. International journal of clinical pharmacology research, 1999, Volume: 19, Issue:3 Topics: Adult; Amikacin; Antitubercular Agents; Female; Humans; Kanamycin; Male; Middle Aged; Tuberculosis, Multidrug-Resistant	1999

Other Studies

72 other study(ies) available for amikacin and Tuberculosis, Drug-Resistant

Article	Year
Design and synthesis of novel quinoxaline derivatives as potential candidates for treatment of multidrug-resistant and latent tuberculosis. Bioorganic & medicinal chemistry letters, 2016, May-01, Volume: 26, Issue:9 Topics: Animals; Antitubercular Agents; Cell Line; Cyclic N-Oxides; Drug Resistance, Multiple, Bacterial; Latent Tuberculosis; Mice; Mycobacterium tuberculosis; Quinoxalines; Tuberculosis, Multidrug-Resistant	2016
Role of Epistasis in Amikacin, Kanamycin, Bedaquiline, and Clofazimine Resistance in Mycobacterium tuberculosis Complex. Antimicrobial agents and chemotherapy, 2021, 10-18, Volume: 65, Issue:11 Topics: Amikacin; Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Epistasis, Genetic; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2021
Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study. The Lancet. Infectious diseases, 2022, Volume: 22, Issue:2 Topics: Adult; Amikacin; Australia; Capreomycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Ethionamide; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis; Tuberculosis, Multidrug-Resistant	2022
Use of Whole-Genome Sequencing to Predict Microbiology spectrum, 2022, 04-27, Volume: 10, Issue:2 Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant	2022
Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa. Scientific reports, 2022, 06-27, Volume: 12, Issue:1 Topics: Amikacin; Antitubercular Agents; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; South Africa; Tuberculosis, Multidrug-Resistant	2022
Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs. Microbiology spectrum, 2022, 12-21, Volume: 10, Issue:6 Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant	2022
In silico evaluation of WHO-endorsed molecular methods to detect drug resistant tuberculosis. Scientific reports, 2022, 10-22, Volume: 12, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Genotype; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; World Health Organization	2022
Molecular Characterization of Resistance to Second-Line Anti-Mycobacterial Drugs among Clinical Isolates of Multidrug-Resistant Mycobacterium tuberculosis. Clinical laboratory, 2023, Jan-01, Volume: 69, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Iran; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2023
Clinical Evaluation of the XDR-LFC Assay for the Molecular Detection of Isoniazid, Rifampin, Fluoroquinolone, Kanamycin, Capreomycin, and Amikacin Drug Resistance in a Prospective Cohort. Journal of clinical microbiology, 2023, 03-23, Volume: 61, Issue:3 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant	2023
Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa. PloS one, 2023, Volume: 18, Issue:2 Topics: Adult; Amikacin; Aminosalicylic Acid; Antitubercular Agents; Ethionamide; Female; HIV Infections; Hospitals; Humans; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; South Africa; Tuberculosis, Multidrug-Resistant	2023
Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia. BMC infectious diseases, 2023, Sep-28, Volume: 23, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Latvia; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing	2023
Antimicrobial drug resistant features of Mycobacterium tuberculosis associated with treatment failure. PloS one, 2023, Volume: 18, Issue:10 Topics: Amikacin; Antitubercular Agents; Humans; Isoniazid; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant; Verapamil	2023
A cost comparison of amikacin therapy with bedaquiline, for drug-resistant tuberculosis in the UK. The Journal of infection, 2020, Volume: 80, Issue:1 Topics: Amikacin; Antitubercular Agents; Costs and Cost Analysis; Diarylquinolines; Humans; Retrospective Studies; Tuberculosis, Multidrug-Resistant; United Kingdom	2020
Inhibition of Transglutaminase 2 as a Potential Host-Directed Therapy Against Frontiers in immunology, 2019, Volume: 10 Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Autophagy; Cystamine; Cysteamine; DNA Replication; Drug Synergism; Granuloma; GTP-Binding Proteins; Humans; Macrophages; Mycobacterium tuberculosis; Protein Glutamine gamma Glutamyltransferase 2; THP-1 Cells; Transglutaminases; Tuberculosis, Multidrug-Resistant	2019
Prevalence of Pre-Existing Hearing Loss Among Patients With Drug-Resistant Tuberculosis in South Africa. American journal of audiology, 2020, Jun-08, Volume: 29, Issue:2 Topics: Adolescent; Adult; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antitubercular Agents; Audiometry; Auditory Threshold; Cross-Sectional Studies; Female; Hearing Loss; HIV Infections; Humans; Hypoalbuminemia; Kanamycin; Male; Middle Aged; Ototoxicity; Prevalence; Renal Insufficiency; South Africa; Thinness; Tuberculosis, Multidrug-Resistant; Young Adult	2020
Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report. BMC infectious diseases, 2020, May-24, Volume: 20, Issue:1 Topics: Amikacin; Antitubercular Agents; Diarylquinolines; Drug Resistance, Bacterial; Female; Humans; Imipenem; Levofloxacin; Macrolides; Mycobacterium fortuitum; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Soft Tissue Injuries; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam; Young Adult	2020
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2020, Volume: 85 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2020
Analysis of Serial Multidrug-Resistant Tuberculosis Strains Causing Treatment Failure and Within-Host Evolution by Whole-Genome Sequencing. mSphere, 2020, 12-23, Volume: 5, Issue:6 Topics: Amikacin; Antitubercular Agents; China; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Retrospective Studies; Treatment Failure; Tuberculosis, Multidrug-Resistant; Whole Genome Sequencing	2020
Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB). BMC infectious diseases, 2021, Mar-10, Volume: 21, Issue:1 Topics: Adult; Amikacin; Antitubercular Agents; Cohort Studies; Drug Monitoring; Female; Hearing Loss; Humans; Male; Retrospective Studies; Tinnitus; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization	2021
Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review. The American journal of tropical medicine and hygiene, 2021, 03-15, Volume: 104, Issue:5 Topics: Adult; Amikacin; Antitubercular Agents; Clofazimine; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Lost to Follow-Up; Male; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Pakistan; Pyrazinamide; Retrospective Studies; Survival Analysis; Treatment Failure; Tuberculosis, Multidrug-Resistant	2021
Analysis of rrs gene mutations in amikacin resistant clinical isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. Microbial pathogenesis, 2017, Volume: 108 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Base Sequence; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Pakistan; RNA, Ribosomal, 16S; Tuberculosis, Multidrug-Resistant	2017
Role of second-line injectable antituberculosis drugs in the treatment of MDR/XDR tuberculosis. International journal of antimicrobial agents, 2017, Volume: 50, Issue:2 Topics: Amikacin; Antitubercular Agents; Follow-Up Studies; Humans; Injections, Intramuscular; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2017
Adverse Effects and Choice between the Injectable Agents Amikacin and Capreomycin in Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9 Topics: Acute Kidney Injury; Adult; Amikacin; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Female; Hearing Loss; Humans; Hypokalemia; Male; Mycobacterium tuberculosis; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult	2017
Electrolytes imbalance caused by amikacin in patients receiving multi drug resistance- tuberculosis treatment at Hazara region Kpk, Pakistan. Tuberkuloz ve toraks, 2017, Volume: 65, Issue:3 Topics: Adult; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Hypokalemia; Male; Middle Aged; Pakistan; Potassium; Risk Factors; Tuberculosis, Multidrug-Resistant; Water-Electrolyte Imbalance; Young Adult	2017
Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis. The American journal of tropical medicine and hygiene, 2018, Volume: 98, Issue:2 Topics: Adult; Amikacin; Carbapenem-Resistant Enterobacteriaceae; Clofazimine; Drug Monitoring; Humans; Linezolid; Male; Moxifloxacin; Netherlands; Prevalence; Prothionamide; Refugees; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Multidrug-Resistant	2018
Evaluation of Nitrate Reductase Assay for Early Detection of Multi and Extensively Drug Resistance Tuberculosis in our Setup. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:1 Topics: Amikacin; Antitubercular Agents; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitrate Reductase; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant	2018
Molecular characterization of mutations associated with resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients from high prevalence tuberculosis city in Morocco. BMC infectious diseases, 2018, 02-27, Volume: 18, Issue:1 Topics: Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Morocco; Mutation; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Tuberculosis, Multidrug-Resistant	2018
Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates. Annals of laboratory medicine, 2018, Volume: 38, Issue:4 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; Semiconductors; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2018
Sequential analysis as a tool for detection of amikacin ototoxicity in the treatment of multidrug-resistant tuberculosis. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2018, Volume: 44, Issue:2 Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Audiometry, Pure-Tone; Auditory Threshold; Early Diagnosis; Female; Hearing; Hearing Disorders; Hearing Tests; Humans; Longitudinal Studies; Male; Middle Aged; Otoacoustic Emissions, Spontaneous; Prospective Studies; Reproducibility of Results; Statistics as Topic; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2018
Overexpression of eis without a mutation in promoter region of amikacin- and kanamycin-resistant Mycobacterium tuberculosis clinical strain. Annals of clinical microbiology and antimicrobials, 2018, Jul-16, Volume: 17, Issue:1 Topics: Acetyltransferases; Amikacin; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Gene Expression; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Promoter Regions, Genetic; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2018
Role of M.tuberculosis protein Rv2005c in the aminoglycosides resistance. Microbial pathogenesis, 2019, Volume: 132 Topics: Amikacin; Aminoglycosides; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Protein Interaction Maps; Tuberculosis, Multidrug-Resistant	2019
Nephrotoxicity and ototoxic symptoms of injectable second-line anti-tubercular drugs among patients treated for MDR-TB in Ethiopia: a retrospective cohort study. BMC pharmacology & toxicology, 2019, 05-23, Volume: 20, Issue:1 Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; Capreomycin; Child; Child, Preschool; Creatinine; Ethiopia; Female; HIV Infections; Humans; Kanamycin; Kidney Diseases; Male; Middle Aged; Ototoxicity; Retrospective Studies; Tuberculosis, Multidrug-Resistant; Young Adult	2019
Towards tailored regimens in the treatment of drug-resistant tuberculosis: a retrospective study in two Italian reference Centres. BMC infectious diseases, 2019, Jun-28, Volume: 19, Issue:1 Topics: Adult; Amikacin; Antitubercular Agents; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Italy; Laboratories, Hospital; Linezolid; Male; Meropenem; Retrospective Studies; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2019
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016). BMC pulmonary medicine, 2019, Jul-10, Volume: 19, Issue:1 Topics: Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Eswatini; Fluoroquinolones; Gene Frequency; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sequence Analysis, DNA; Somalia; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Uganda	2019
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:2 Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant	2013
Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required? The European respiratory journal, 2013, Volume: 42, Issue:4 Topics: Adult; Amikacin; Antitubercular Agents; Audiology; Drug Monitoring; Female; Hearing Loss; Humans; Kidney; Male; Retrospective Studies; Tuberculosis, Multidrug-Resistant	2013
Plasma drug activity in patients on treatment for multidrug-resistant tuberculosis. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2 Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Cycloserine; Ethionamide; Female; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Sputum; Tanzania; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
Second-line drug susceptibility breakpoints for Mycobacterium tuberculosis using the MODS assay. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2014, Volume: 18, Issue:2 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; India; Kanamycin; Microbial Sensitivity Tests; Microscopy; Moldova; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Peru; Predictive Value of Tests; Reproducibility of Results; South Africa; Sputum; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2014
Molecular and phenotypic characterization of multidrug-resistant Mycobacterium tuberculosis isolates resistant to kanamycin, amikacin, and capreomycin in China. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2014, Volume: 33, Issue:11 Topics: Amikacin; Antitubercular Agents; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Point Mutation; Tuberculosis, Multidrug-Resistant	2014
Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss. BMC infectious diseases, 2014, Oct-09, Volume: 14 Topics: Adolescent; Adult; Amikacin; Antitubercular Agents; Drug Administration Schedule; Female; Hearing Loss; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2014
Genotypic susceptibility testing of Mycobacterium tuberculosis isolates for amikacin and kanamycin resistance by use of a rapid sloppy molecular beacon-based assay identifies more cases of low-level drug resistance than phenotypic Lowenstein-Jensen testin Journal of clinical microbiology, 2015, Volume: 53, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genotyping Techniques; Humans; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Tuberculosis; Tuberculosis, Multidrug-Resistant	2015
Disparities in capreomycin resistance levels associated with the rrs A1401G mutation in clinical isolates of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:1 Topics: Amikacin; Antibiotics, Antitubercular; Capreomycin; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2015
Combination of amikacin and doxycycline against multidrug-resistant and extensively drug-resistant tuberculosis. International journal of antimicrobial agents, 2015, Volume: 45, Issue:4 Topics: Amikacin; Antitubercular Agents; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pilot Projects; Tuberculosis, Multidrug-Resistant	2015
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:3 Topics: Adult; Aged; Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Ethionamide; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2016
Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis. International journal of antimicrobial agents, 2015, Volume: 46, Issue:3 Topics: Adult; Amikacin; Antitubercular Agents; Biostatistics; Drug Monitoring; Female; Humans; Kanamycin; Male; Models, Statistical; Retrospective Studies; Specimen Handling; Tuberculosis, Multidrug-Resistant; Young Adult	2015
Amikacin Concentrations Predictive of Ototoxicity in Multidrug-Resistant Tuberculosis Patients. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:10 Topics: Adult; Amikacin; Antitubercular Agents; Area Under Curve; Audiometry; Clinical Decision-Making; Female; Hearing Loss, Sensorineural; Humans; Machine Learning; Male; Middle Aged; Probability; ROC Curve; Tuberculosis, Multidrug-Resistant	2015
Comparing amikacin and kanamycin-induced hearing loss in multidrug-resistant tuberculosis treatment under programmatic conditions in a Namibian retrospective cohort. BMC pharmacology & toxicology, 2015, Dec-10, Volume: 16 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Body Weight; Chi-Square Distribution; Child; Child, Preschool; Coinfection; Hearing Loss; Hearing Tests; HIV Infections; Humans; Incidence; Infant; Infant, Newborn; Kanamycin; Logistic Models; Middle Aged; Namibia; Retrospective Studies; Risk Assessment; Risk Factors; Sex Factors; Tuberculosis, Multidrug-Resistant	2015
Drug-resistant tuberculosis plagues India. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Mar-15, Volume: 188, Issue:5 Topics: Amikacin; Antitubercular Agents; Capreomycin; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; India; Isoniazid; Kanamycin; Medication Adherence; Mycobacterium tuberculosis; Nonprescription Drugs; Rifampin; Tuberculosis, Multidrug-Resistant	2016
Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables. International journal of mycobacteriology, 2016, Volume: 5, Issue:1 Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Genes, rRNA; Genotype; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Promoter Regions, Genetic; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2016
Performance of the New Version (v2.0) of the GenoType MTBDRsl Test for Detection of Resistance to Second-Line Drugs in Multidrug-Resistant Mycobacterium tuberculosis Complex Strains. Journal of clinical microbiology, 2016, Volume: 54, Issue:6 Topics: Amikacin; Antitubercular Agents; Capreomycin; Drug Resistance, Bacterial; Fluoroquinolones; Genes, Bacterial; Genotyping Techniques; Humans; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Sensitivity and Specificity; Tuberculosis, Multidrug-Resistant	2016
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China. Scientific reports, 2016, 05-06, Volume: 6 Topics: Amikacin; China; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant	2016
Determination of MIC Breakpoints for Second-Line Drugs Associated with Clinical Outcomes in Multidrug-Resistant Tuberculosis Treatment in China. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:8 Topics: Adolescent; Adult; Aged; Amikacin; Antitubercular Agents; China; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prospective Studies; Pyrazinamide; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2016
Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Amikacin; Antitubercular Agents; Dose-Response Relationship, Drug; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant	2016
Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Artificial Intelligence; Botswana; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Models, Theoretical; Mycobacterium tuberculosis; Regression Analysis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult	2016
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand. The European respiratory journal, 2016, Volume: 48, Issue:4 Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary	2016
Molecular Investigation of Resistance to Second-Line Injectable Drugs in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis in France. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:2 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; France; Humans; Kanamycin; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2017
Sequence analyses of just four genes to detect extensively drug-resistant Mycobacterium tuberculosis strains in multidrug-resistant tuberculosis patients undergoing treatment. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; Extensively Drug-Resistant Tuberculosis; Humans; Mutation; Mycobacterium tuberculosis; Ofloxacin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant; Uzbekistan	2009
Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin. Indian journal of experimental biology, 2009, Volume: 47, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Tuberculosis, Multidrug-Resistant	2009
High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Georgia (Republic); Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2009
Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences of the United States of America, 2009, Nov-24, Volume: 106, Issue:47 Topics: Acetyltransferases; Amikacin; Anti-Bacterial Agents; Antigens, Bacterial; Antitubercular Agents; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Promoter Regions, Genetic; Transcription, Genetic; Tuberculosis, Multidrug-Resistant	2009
Amikacin-induced hypomagnesaemic tetany complicating multidrug-resistant tuberculosis treatment. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2010, Volume: 14, Issue:5 Topics: Adult; Amikacin; Antitubercular Agents; Drug Monitoring; Female; Humans; Hypokalemia; Magnesium; Magnesium Deficiency; Tetany; Tuberculosis, Multidrug-Resistant	2010
Mutations in the rrs A1401G gene and phenotypic resistance to amikacin and capreomycin in Mycobacterium tuberculosis. Microbial drug resistance (Larchmont, N.Y.), 2012, Volume: 18, Issue:2 Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Polymerase Chain Reaction; RNA, Ribosomal, 16S; Sequence Analysis, DNA; South Africa; Tuberculosis, Multidrug-Resistant	2012
Mycobacterium tuberculosis population structure determines the outcome of genetics-based second-line drug resistance testing. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5 Topics: Amikacin; Antitubercular Agents; Bacterial Typing Techniques; Base Sequence; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Polymorphism, Single Nucleotide; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant	2012
Drug susceptibility of Mycobacterium tuberculosis Beijing genotype and association with MDR TB. Emerging infectious diseases, 2012, Volume: 18, Issue:4 Topics: Amikacin; Antitubercular Agents; Aza Compounds; Bacterial Proteins; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genotype; Isoniazid; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Quinolines; Rifampin; Statistics, Nonparametric; Tuberculosis, Multidrug-Resistant	2012
Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2004, Volume: 8, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Communicable Disease Control; Cycloserine; Directly Observed Therapy; Drug Combinations; Ethionamide; Hong Kong; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Program Evaluation; Recurrence; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2004
[A case of pulmonary multiresistant Mycobacterium bovis tuberculosis in Madagascar]. Archives de l'Institut Pasteur de Madagascar, 2003, Volume: 69, Issue:1-2 Topics: Amikacin; Antitubercular Agents; Capreomycin; Chronic Disease; Ciprofloxacin; Cough; DNA, Bacterial; Drug Therapy, Combination; Ethionamide; Humans; Kanamycin; Madagascar; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium bovis; Ofloxacin; Patient Compliance; Polymorphism, Restriction Fragment Length; Sputum; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2003
[Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents]. Problemy tuberkuleza i boleznei legkikh, 2007, Issue:5 Topics: Adolescent; Amikacin; Antitubercular Agents; Child; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Male; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2007
The management of mycobacterial infections in HIV seropositive individuals. Jefferiss Wing Therapeutics and Protocols Group. International journal of STD & AIDS, 1996, Volume: 7, Issue:4 Topics: Adrenal Cortex Hormones; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Clofazimine; Drug Therapy, Combination; Ethambutol; HIV Infections; Humans; Isoniazid; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Nontuberculous Mycobacteria; Practice Guidelines as Topic; Pyrazinamide; Pyridoxine; Radiography; Rifabutin; Rifampin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1996
Kinetics and toxicity of liposomal and conventional amikacin in a patient with multidrug-resistant tuberculosis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1998, Volume: 17, Issue:11 Topics: Aged; Amikacin; Anti-Bacterial Agents; Antitubercular Agents; Drug Carriers; Drug Therapy, Combination; Humans; Liposomes; Male; Mycobacterium tuberculosis; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant	1998
[Breast abscess and pregnancy toxemia revealing multidrug resistant tuberculosis]. Revue des maladies respiratoires, 1999, Volume: 16, Issue:5 Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Breast Diseases; Bronchoscopy; Cesarean Section; Ciprofloxacin; Drug Therapy, Combination; Eclampsia; Ethambutol; Female; Follow-Up Studies; Humans; Infant, Newborn; Pregnancy; Pregnancy Complications, Infectious; Pyrazinamide; Radiography, Thoracic; Time Factors; Tomography, X-Ray Computed; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	1999
Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2001, Feb-15, Volume: 32, Issue:4 Topics: Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Humans; Injections, Spinal; Levofloxacin; Male; Mycobacterium tuberculosis; Ofloxacin; Tuberculosis, Meningeal; Tuberculosis, Multidrug-Resistant	2001
Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2002, Volume: 6, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Audiometry; Child; Creatinine; Female; Hearing Loss, Bilateral; Humans; Kanamycin; Kidney; Kidney Diseases; Male; Middle Aged; Retrospective Studies; Streptomycin; Time Factors; Tuberculosis; Tuberculosis, Multidrug-Resistant	2002